Aveanna Healthcare Holdings Inc

AVAH remains in a Stage 2 advancing trend with bullish medium-term asymmetry despite an active Bullish Exhaustion pattern signaling weakening momentum. Price is currently pulling back into the rising 9/21 EMA support band after an extended rally and showing no clear reversal. Short-term timing is neutral amid this pullback, so we will stalk shallow pullbacks into the EMA support zone for buy-on-dip participation.

• ↑Revenue surged 16.8% YoY to $590M in Q2 2025
• ↑Adjusted EBITDA rose 93.6% to $88.3M on cost initiatives
• ↓Operating cash only $4.3M and FCF negative $3.8M signal strain